Navigation Links
Biovista und DART Therapeutics nehmen Zusammenarbeit auf, um auf Duchenne-Muskeldystrophie abzielende Medikamente neu zu positionieren
Date:3/26/2013

28;higkeiten bei der Neupositionierung von Medikamenten", sagte Aris Persidis, Präsident von Biovista. "Wir glauben, dass diese Art von Kooperationen bezeichnend für Interessengruppen ist, die sich darum bemühen, auf neuartige Weisen Therapien zu entwickeln, die direkter ihre spezifischen Bedürfnisse ansprechen, und wir freuen uns auf die Zusammenarbeit mit DART Therapeutics."

Über Biovista

Biovista ist ein nicht börsennotiertes Biotechnologie-Unternehmen, das sich auf die Ermittlung neuer Anwendungsbereiche für bereits zugelassene Medikamente sowie die Erstellung von Profilen zu ihren Nebenwirkungen spezialisiert hat, die über das entsprechende Wirkprinzip ermittelt werden. Biovista entwickelt eine eigene Produktpipeline von Medikamenten für das ZNS, die Onkologie sowie Autoimmun- und seltene Krankheiten. Biovista arbeitet mit biopharmazeutischen Unternehmen an der Erweiterung von Indikationsbereichen und der Risikobereinigung ihrer Portfolios zusammen. Sie unterstützt zudem die FDA bei der Vorhersage von Nebenwirkungen und Interessengruppen von Patienten bei der Neupositionierung von Medikamenten. (http://www.biovista.com).

Über DART Therapeutics

DART Therapeutics Inc. aus Cambridge, Massachusetts, ist ein Biotechnologie-Unternehmen, da ein neues Modell für Medikamentenentwicklung auf seltene pädiatrische neuromuskuläre Krankheiten anwendet. Beim DART-Modell haben sich Patientenstiftungen und Biotechnologie-Industrie-Veteranen zusammengeschlossen, um Einfluss auf ein zentrales Problem bei seltenen Krankheiten zu nehmen: die rasche Therapie-Entwicklung. DART konzentriert sich auf DMD, eine tödliche neuromuskuläre Erkrankung, für die es keine wirksame Behandlung gibt. (http://www.dartrx.com).

Kontakte:
Biovista, Inc.
Aris Persidis
+1
'/>"/>

SOURCE Biovista, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
2. Nile Therapeutics Reports 2011 Third Quarter Financial Results
3. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
4. Fate Therapeutics Strengthens Its iPSC Platform
5. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
6. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
7. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
8. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Aratana Therapeutics Completes $15 Million Series B Financing
11. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... , Sept. 29, 2014  Ten of the ... of cartilage repair, regeneration, allograft reconstruction and research ... the world gathered to discuss the future of ... of Regenerative Medicine symposium, Cartilage Regeneration: State ... included Orthopedic Biosurgery, Minced Juvenile Allograft, and State ...
(Date:9/29/2014)... 29, 2014 Research and Markets  has ... Gas Analyzer, and Gas Chromatograph Market by Type , ... Global Trends & Forecast to 2013 - 2020" ... analyzer is a process analytical instrument that provides chemical ... redefined the way by which companies carry out their ...
(Date:9/29/2014)... NEW YORK , Sept. 29, 2014 /PRNewswire/ ... firm, and The Channel Group ("TCG"), a leader ... transition advisors, have formed an alliance to expand ... to prospective clients. With the alliance, Burnham Securities ... in the scientific, clinical medicine and management in ...
(Date:9/29/2014)... Israel , September 29, 2014 ... novel immunomodulators for severe infections, today announced that the ... has awarded Atox Bio with a contract valued up ... of AB103 to treat Necrotizing Soft Tissue Infections (NSTI) ... threats that end in sepsis. BARDA awarded ...
Breaking Biology Technology:World Renowned Experts Discuss Future Of Cartilage Regeneration 2World Renowned Experts Discuss Future Of Cartilage Regeneration 3Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 2Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 3Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 4Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 2Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 3Atox Bio Awarded Contract Worth up to $24 Million for the Development of AB103 by the Biomedical Advanced Research and Development Authority (BARDA) 2
... IDIX ) announced today that Idenix management will ... Health Care Conference on Monday, May 18, 2009 at 8:40 ... webcast of the company presentation can be accessed under "Calendar ... www.idenix.com . Please log in approximately 5-10 minutes ...
... Trait Will Benefit Everyone from Farmers to Consumers. , ... Wilmington, DE ... reached a regulatory milestone for its next generation of healthier soybean products. ... Canada and the Canadian Food Inspection Agency that its ...
... WHAT: GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, ... company developing human, ... Virus) and other infectious agents to share their strategy for, ... plans to expand preventative trials, currently in, ...
Cached Biology Technology:DuPont Receives Canadian Regulatory Approval for High Oleic Soybean Trait 2DuPont Receives Canadian Regulatory Approval for High Oleic Soybean Trait 3
(Date:9/29/2014)... According to a NASA story from 2009, "human activities in ... fire emissions issue. Palm oil is increasingly grown for use ... fats in processed foods. It has become the most widely ... in recent years to surpass that of soybean oil. , ... has to be cleared to grow the crop, and the ...
(Date:9/29/2014)... get a bad rap, and understandably so. The grain-of-rice-sized ... of millions of acres in the Western U.S. and ... to popular belief, these pests may not be to ... recently swept through the region. Instead, weather and topography ... fires than these bark-boring beetles. , New research led ...
(Date:9/29/2014)... A review article published online in Behavioral Brain ... in the brain as a result of chronic alcohol ... cycle. , Clinical assessments and research indicate that ... disrupted sleep. This can occur when people are actively ... they are abstaining. , "Sleep-wake disturbances can last ...
Breaking Biology News(10 mins):Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 2Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 4
... civilian personnel from the U.S. Armed Forces, as well ... and other first-responder personnel from throughout the United States, ... attend the 2009 Force Protection Equipment Demonstration (FPED VII). ... and Marine Corps Base, Quantico, VA, during May 19-21.The ...
... Team Up to Provide High Volume Transaction Solution ... Calif. and NEW YORK, May 11 Communication ... CICI), a leading supplier of electronic signature solutions ... and the recognized leader** in biometric signature verification ...
... EfficiencyWALL, N.J., May 19 BIO-key International, ... in finger-based biometric identification and wireless public ... are deploying BIO-key,s WEB-key(R) biometric identification software ... charging, or eCharging system.(Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ...
Cached Biology News:Demonstration Features Commercial Technology for Combating Terrorism 2Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 2Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 3Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 4Striata and CIC Launch Integrated eSignature, eDelivery, and eBilling for the Financial Services Industry 5Minnesota Counties Secure New Criminal Charging System With BIO-key(R) Fingerprint Biometrics 2Minnesota Counties Secure New Criminal Charging System With BIO-key(R) Fingerprint Biometrics 3
... were designed for full-length gene cloning and ... identify the desired cDNA clone. The first ... "Master Plate," where each well contains plasmid ... positive well(s) by gel electrophoresis of the ...
... Panels were designed for full-length gene cloning ... to identify the desired cDNA clone. The ... 96-well "Master Plate," where each well contains ... the positive well(s) by gel electrophoresis of ...
... Prepared by a modification of the ... Biotechnol. Bioeng., 11 , ... will yield an A 260 ... water (1 cm light path). Physical ...
... Dithiothreitol DTT White solid.. PACKAGED UNDER ... thiols, so reaction is "driven" to completion. A ... waxy surfactant found in many other preparations. Blocks ... Purity: ≥97% by titration. Contaminants: Heavy ...
Biology Products: